Work and career can pose additional challenges for individuals living with endometriosis, where severe menstrual pain and excessive or irregular bleeding are common symptoms.

In the UK, a standard aims at helping employers support the needs of menstruating and menopausal employees. A comprehensive guide provides businesses with practical steps to create a more inclusive and supportive environment for all.

By addressing misconceptions, tackling stigma, and implementing practical adjustments, organizations can significantly improve employee well-being, and may increase employee retention and reduce costs related to recruitment and training.

The standard is a commendable initiative that should inspire many organizations in the UK and elsewhere. Learn more about British Standard BS 30416 Menstruation, menstrual health and menopause in the workplace: https://knowledge.bsigroup.com/articles/bs-30416-menstrual-and-menopausal-health-matters-in-your-workplace

Gesynta Pharma is dedicated to the development of better treatments for endometriosis patients, with promising preclinical data for vipoglanstat and a phase II study coming.